FibroGen (NASDAQ: FGEN) reported Q2 EPS of $1.26, $1.77 better than the analyst estimate of ($0.51). Revenue for the quarter ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE